Augmented pulse-spray thrombolysis with tPA by early pulsed intrathrombic plasminogen enrichment

Journal of Vascular and Interventional Radiology

Volumn 9, Issue 4, 1998, Pages 618-625

  Lim, Gregory M ^a   Bookstein, Joseph J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Plasminogen; Thrombolysis, pharmacomechanical; Tissue plasminogen activator; Urokinase

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; FIBRINOLYTIC THERAPY; INTRALESIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RABBIT; THROMBOSIS;

EID: 0031845424     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1051-0443(98)70332-X     Document Type: Article

References (33)

1. Dotter CT, Rosch J, Seaman AJ. Selective clot lysis with low-dose streptokinase. Radiology 1974; 111: 31-37.
2. Katzen BT, Edwards KC, Albert AS, van Breda A. Low-dose direct fibrinolysis in peripheral vascular disease. J Vasc Surg 1984; 1:718-722.
3. McNamara TO, Fischer JR. Thrombolysis of peripheral arterial and graft occlusions: improved results using high-dose urokinase. AJR 1985; 144:769-775.
4. Cragg AH, Smith TP, Corson JD, et al. Two urokinase dose regimens in native arterial and graft occlusions: initial results of a prospective randomized trial. Radiology 1991; 178:681-686.
5. Gardiner GA Jr, Koltun W, Kandarpa K, et al. Thrombolysis of occluded femoropopliteal grafts. AJR 1986; 147:621-626.
6. LeBlang S, Becker G, Benenati JF, Zemel G, Katzen BT, Sallee SS. Low-dose urokinase regimen for the treatment of lower extremity arterial and graft occlusions: experience in 132 cases. JVIR 1992; 3:475-483.
7. Bookstein JJ, Valji K. How I do it. Pulse-spray pharmacomechanical thrombolysis. Cardiovasc Intervent Radiol 1992; 15:228-233.
8. Armon MP, Yusuf SW, Whitaker SC, Gregson RW, Wenham PW, Hopkinson BR. Results of 100 cases of pulse-spray thrombolysis for acute and subacute leg ischemia. Br J Surg 1997; 84:47-50.
9. Kandarpa K, Chopra PS, Aruny JE, et al. Intraarterial thrombolysis of lower extremity occlusions: prospective, randomized comparison of forced periodic infusion and conventional slow infusion. Radiology 1993; 188:861-867.
10. Sullivan K, Gardiner G, Shapiro MJ, Bonn JB, Levin DC. Acceleration of thrombolysis with a high-dose transthrombus bolus technique. Radiology 1989; 173:805-808.
11. Mewissen MW, Meissner MH, Durham JD. Catheter directed thrombolysis for symptomatic lower extremity DVT: preliminary results of a national multicenter registry. Radiology 1997; 205(suppl 1):273.
12. Bjarnason H, Kruse JR, Asinger DA, et al. Iliofemoral deep venous thrombosis: safety and efficacy outcomes during 5 years of catheter-directed thrombolytic therapy. JVIR 1997; 8:405-418.
13. Alkjearsig N, Fletcher A, Sherry S. The mechanism of clot dissolution by plasmin. J Clin Invest 1959; 38:1086-1095.
14. Bookstein JJ, Saldinger E. Accelerated thrombolysis: in vitro evaluation of agents and methods of administration. Invest Radiol 1985; 20:731-735.
15. Valji K, Bookstein JJ. Fibrinolysis with intrathrombic injections of urokinase and tissue-type plasminogen activator: results in a new model of subacute venous thrombosis. Invest Radiol 1987; 22:23-27.
16. Sakharov DV, Rijken DC. Superficial accumulation of plasminogen during plasma clot lysis. Circulation 1995; 92:1883-1890.
17. Fleury V, Angles-Cano E. Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxyterminal lysines. Biochemistry 1991; 30:7630-7638.
18. Suenson E, Lutzen O, Thorsen S. Initial plasmin-degradation of fibrin as a basis of a positive feedback mechanism in fibrinolysis. Eur J Biochem 1984; 140:513-522.
19. Tran-Thag C, Kruithop EKO, Bachmann F. Tissue-type plasminogen activator increases the binding of glu-plasminogen to clots. J Clin Invest 1984; 74:2009-2016.
20. Harpel PC, Chang TX, Verderber E. Tissue plasminogen activator and urokinase mediate the binding of glu-plasminogen to plasma fibrin I. J Biol Chem 1985; 260:4432-4440.
21. Valji K, Bookstein JJ. Efficacy of adjunctive intrathrombic heparin with pulse-spray thrombolysis in rabbit inferior vena cava thrombosis. Invest Radiol 1992; 27:912-917.
22. Lijnen HR, DeWreede K, Demarsin E, Collen D. Biological and thrombolytic properties of proenzyme and active forms of human urokinase-IV: variability of fibrinolytic response of plasma of several mammalian species. Thromb Haemost 1984; 52:31-33.
23. Collen D. On the regulation and control of fibrinolysis. Thromb Haemost 1980; 43:77-89.
24. Bohmfalk J, Fuller G. Plasminogen is synthesized by primary cultures of rat hepatocytes. Science 1980; 209:408-410.
25. Rakoczi I, Wiman B, Collen D. On the biological significance of the specific interaction between fibrin, plasminogen and antiplasmin. Biochim Biophysic Acta 1978; 540:295-300.
26. Whitaker AN, Rowe EA, Masci PP, Joe F, Gaffney PJ. The binding of glu-and lys-plasminogens to fibrin and their subsequent effects on fibrinolysis. Thromb Res 1980; 19: 381-391.
27. Nieuwenhuizen W, Vermond A, Voskuilen M, Traas DW, Verheijen JH. Identification of a site in fibrinogen which is involved in the acceleration of plasminogen activation by tissue-type plasminogen activator. Biochim Biophy ACTA 1983; 748:86.
28. Sabovic M, Lijnen HR, Keber D, Collen D. Correlation between progressive adsorption of plasminogen to blood clots and their sensitivity to lysis. Thromb Haemost 1990; 64: 450-454.
29. Onundarson PT, Francis CW, Marder VJ. Depletion of plasminogen in vitro or during thrombolytic therapy limits fibrinolytic potential. J Lab Clin Med 1992; 120:120-128.
30. Telsner V, Witte G. Effectiveness of intra-arterial plasminogen in combination with percutaneous transluminal angioplasty (PTA) or catheter assisted lysis (CL) in patients with chronic peripheral occlusion disease of the lower limbs. Haemostasis 1988; 18(suppl 1):139-156.
31. Stoughton J, Ouriel K, Shortell CK, Cho J-S, Marder VJ. Plasminogen acceleration of urokinase thrombolysis. J Vasc Surg 1994; 19:298-305.
32. Christensen U. C-terminal lysine residues of fibrinogen fragments essential for binding to plasminogen. FEBS Lett 1985; 182:43.
33. Jang I-K, Gold HK, Zisking AA, et al. Differential sensitivity of erythrocyte-rich and platelet rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. Circulation 1989; 79:920-928.